- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: November 2014
- Public Summary Document (PSD) November 2014 PBAC Meeting - PDF
- Public Summary Document (PSD) November 2014 PBAC Meeting - Word
Crizotinib – November 2014
Crizotinib; 200 mg capsule, 60 and 250 mg capsule, 60; Xalkori®
Last updated
6 March 2015